AbbVie to Present IBD Research at Digestive Disease Week

AbbVie to Present IBD Research at Digestive Disease Week
Biopharmaceutical company AbbVie is going to present 18 abstracts regarding its gastroenterology and hepatology programs at the Digestive Disease Week (DDW), taking place between May 16th and 19th in Washington, D.C. Among the abstracts, AbbVie will feature data on clinical studies conducted by the company to assess the safety and efficacy of HUMIRA (adalimumab), a treatment

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *